The synthesis and photodynamic properties of meso-substituted, cationic porphyrin derivatives in HeLa cells
Source abstract
Abstract
A series of asymmetric porphyrins with varying substituents, such as 4-hydrophenyl and N-methyl-4-pyridyl, were synthesized and characterized and their cell uptake, intracellular localization, cytotoxicities and phototoxicities were evaluated in vitro. The most phototoxic of the porphyrins synthesized, 5,10-di-(N-methyl-4-pyridyl)-15,20-(4-hydroxyphenyl)-21,23H-porphyrin, which was mainly localized in the mitochondria and displayed low levels of dark toxicity toward human cancer HeLa cells, offers potential application in photodynamic therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Tumor ablation with photodynamic therapy: introduction to mechanism and clinical applications10.1097/01.RVI.0000231977.49263.DE ↗
2. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy10.1016/j.jconrel.2007.06.012 ↗
3. Photodynamic therapy for esophageal diseases: a clinical update10.1055/s-2003-44604 ↗
4. Photodynamic therapy with endogenous protoporphyrin. 9. Basic principles and present clinical-experience10.1016/1011-1344(90)85083-9 ↗
5. Porphyrins and related compounds as photodynamic sensitizers10.1111/j.1749-6632.1975.tb41550.x ↗
6. Photophysical and photobiological processes in the photodynamic therapy of tumours10.1016/S1011-1344(96)07428-3 ↗
7. Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer
8. Photodynamic therapy10.1093/jnci/90.12.889 ↗
9. Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates10.1016/j.jconrel.2008.03.024 ↗
10. The photobiology of photodynamic therapy: cellular targets and mechanisms10.2307/3579816 ↗
11. Mitochondrial photodamage and PDT-induced apoptosis10.1016/S1011-1344(97)00127-9 ↗
12. Mitochondria-based photodynamic anti-cancer therapy10.1016/S0169-409X(01)00126-0 ↗
13. The role of apoptosis in response to photodynamic therapy: what, where, why, and how10.1039/b108586g ↗
14. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked10.1126/science.275.5303.1129 ↗
15. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c10.1016/S0092-8674(00)80085-9 ↗
16. Critical role of mitochondrial reactive oxygen species formation in visible laser irradiation-induced apoptosis in rat brain astrocytes (RBA-1)10.1007/BF02254977 ↗
17. Mitochondria as a pharmacological target10.1124/pr.54.1.101 ↗
18. Mitochondria and human cancer10.2174/156652407779940495 ↗
19. Modica-Napolitano · 2004
20. Hematoporphyrin and hpd – photophysics, photochemistry and phototherapy10.1111/j.1751-1097.1984.tb08871.x ↗
21. Current clinical and preclinical photosensitizers for use in photodynamic therapy10.1021/jm040074b ↗
22. The present and future role of photodynamic therapy in cancer treatment10.1016/S1470-2045(04)01529-3 ↗
23. A review of progress in clinical photodynamic therapy10.1177/153303460500400308 ↗
24. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200nm nanoparticles10.1016/S0928-0987(03)00017-4 ↗
25. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine
26. A mechanistic study of synthesis of meso-tetraphenylporphin10.1002/jhet.5570050513 ↗
27. Partition coefficients and their uses10.1021/cr60274a001 ↗
28. Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions10.1002/(SICI)1099-1409(199803/04)2:2<145::AID-JPP60>3.0.CO;2-2 ↗
29. Photophysical properties of meso-tetraphenylporphyrin and some meso-tetra(hydroxyphenyl)porphyrins10.1111/j.1751-1097.1988.tb02820.x ↗
30. The effects of aggregation on the fluorescence and the triplet-state yield of hematoporphyrin10.1111/j.1751-1097.1985.tb03459.x ↗
31. Aggregation effects on the photophysical properties of porphyrins in relation to mechanisms involved in photodynamic therapy10.1007/978-1-4613-2165-1_28 ↗
32. Cellular aspects of photodynamic therapy for cancer
33. Structure–photodynamic activity relationships of a series of 4-substituted zinc phthalocyanines10.1111/j.1751-1097.1996.tb03017.x ↗
34. Structure and biodistribution relationships of photodynamic sensitizers10.1111/j.1751-1097.1996.tb03093.x ↗
35. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives10.1111/j.1751-1097.1999.tb08284.x ↗
36. Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2 ↗
37. Influence of substitutions in asymmetric porphyrins on intracellular uptake, subcellular localization and phototoxicity in Hela cells10.4015/S1016237208000556 ↗
38. Photodynamic therapy: a mitochondrial inducer of apoptosis10.1038/sj.cdd.4400446 ↗